When selecting a GLP-1, its important to consider: How easily can you get refills Whether the medication fits your budget Whether your doctor can monitor progress regularly If your lifestyle supports the required dosing schedule Choosing a medicine you cannot continue long-term leads to interrupted progress, which slows results
Health Canada has approved Zepbound (tirzepatide) as the first medication in Canada indicated for the treatment of moderate-to-severe obstructive sleep apnea (OSA) in adults living with obesity
The causes of obesity: an in-depth review
However, annual review with your GP is advisable to: Ensure adherence to the injection schedule Monitor for any new or worsening symptoms Consider testing for other autoimmune conditions if symptoms develop (particularly thyroid function, as thyroid disease is commonly associated with pernicious anaemia) [2] Gastric cancer risk: Pernicious anaemia is associated with a slightly increased risk of gastric cancer
If standard approaches are not working, comprehensive blood work may identify an underlying issue
When speaking with your provider, ask specifically about the B6 compound formulation if nausea management is a priority for you